Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2025-12-24 @ 6:48 PM
NCT ID: NCT06568757
Eligibility Criteria: Inclusion Criteria: * Those between the ages of 18-65, * Those who are literate, speak Turkish and have no communication problems, * Those diagnosed with migraine according to the International Classification of Headache Disorders (ICHD-3), * Those who have had headaches for the last three months and are receiving medical treatment for this reason, * Those who want to have cupping therapy, * Those who do not have any bleeding or coagulation disorders, * Those who have not had wet cupping therapy in the last three months, * Those who have a contraindication for wet cupping therapy (e.g. hemoglobin values below 9.5 gr/dl, INR below 1.5), * Those who do not have a history of malignancy, * Those who do not have an open wound in the application area, * Those who do not have any psychiatric disorders Exclusion Criteria: * Patients with any incurable disease, * Patients with a physical disability in the area where the application will be made, * Patients with any skin disease in the area where the application will be made, * Patients with large scar tissue in the area where the application will be made, * Patients with a history of physical trauma in the area where the application will be made in the last three months, * Patients with any peripheral vascular disease in the area where the application will be made, * Patients who have used any complementary and integrative health application in the last three months, * Patients who have received pain blockade treatment in the last year
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 64 Years
Study: NCT06568757
Study Brief:
Protocol Section: NCT06568757